Dergiler / Turkish Journal of Medical Sciences / 2020 / Cilt: 50 - Sayı: 3

Novel coronavirus disease (COVID-19) in children

Sayfa
592–603
Yayın Tarihi
2022-11-05
DOI
—
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

This review aims to summarize the current epidemics, clinical presentations, diagnosis, and treatment of COVID-19 inpediatric patients.

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:Coronavirus disease (COVID-19) was firstly reported at the end of 2019.
📊
Temel Bulgular & Veri:The disease rapidly spread all around the world in afew months and was declared a worldwide pandemic by WHO in March 2020.
💡
Sonuç & Katkı:This review aims to summarize the current epidemics, clinical presentations, diagnosis, and treatment of COVID-19 inpediatric patients.
🔬Tür:Literatür & Derleme Çalışması
📍Kapsam:2019 Verileri
⚙️Değişkenler:Alan Parametreleri

Abstract

Coronavirus disease (COVID-19) was firstly reported at the end of 2019. The disease rapidly spread all around the world in afew months and was declared a worldwide pandemic by WHO in March 2020. By April 9, there were 1,436,198 confirmed COVID-19cases in the world, nearly with 6% mortality rate. This novel infectious disease causes respiratory tract illness that may generally occur asmild upper respiratory tract disease or pneumonia. In older patients and/or patients with underlying conditions, it may result in acuterespiratory distress syndrome, multi organ failure and even death. According to the current literature, children account approximately for1%–5% of diagnosed COVID-19 cases. Generally, COVID-19 seems to be a less severe disease for children than adults. Approximately90% of pediatric patients are diagnosed as asymptomatic, mild, or moderate disease. However, up to 6.7% of cases may be severe. Severeillness is generally seen in patients smaller than 1 year of age and patients who have underlying disesases. The epidemiological andclinical patterns of COVID-19 and treatment approaches in pediatric patients still remain unclear although many pediatric reportsare published. This review aims to summarize the current epidemics, clinical presentations, diagnosis, and treatment of COVID-19 inpediatric patients.

🔖

Bu Makaleye Atıf Yap

DEMİRDAĞ, T. B., TEZER, H. (2022). Novel coronavirus disease (COVID-19) in children. Turkish Journal of Medical Sciences, Cilt: 50 - Sayı: 3, 592–603. https://ajindex.com/articles/610122

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (9)

  1. Li Q, Guan X, Wu P, Wang X, Zhou L et al. Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia. New England Journal of Medicine 2020
  2. 382 (13): 1199-1207. doi: 10.1056/NEJMoa2001316 2. Huang C, Wang Y, Li X, Ren L, Zhao J et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet 2020
  3. 395 (10223): 497-506. doi: 10.1016/S0140- 6736(20)30183-5. 3. Dong Y, Mo X, Hu Y, Qi X, Jiang F et al. Epidemiology of COVID-19 among children In China. Pediatrics 2020. doi: 10.1542/peds.2020-0702 4. Stoecklin BS, Rolland P, Silue Y, Mailles A, Campese C et al. Investigation Team. First cases of coronavirus disease 2019 (COVID-19) in France: surveillance, investigations, and control measures, January 2020. Eurosurveillance 2020
  4. 25 (6): 2000094. 5. Chan JF, Yuan S, Kok KH, To KK, Chu H et al. A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster. Lancet 2020
  5. doi: 10.1093/infdis/jiaa077 6. Chen Z, Fu J, Shu Q Chen Y, Hua C et al. Diagnosis and treatment recommendations for pediatric respiratory infection caused by the 2019 novel coronavirus. World Journal of Pediatrics (2020). doi: 10.1007/s12519-020-00345-5 7. Zhu N, Zhang D, Wang W, Li X, Yang B et al. Coronavirus Investigating, and Research Team. A novel coronavirus from patients with pneumonia in China, 2019. New England Journalof Medicine 2020. doi: 10.1056/NEJMoa2001017 8. Cascella M, Rajnik M, Cuomo A, Dulebohn SC, Napoli RD. Features, Evaluation, and Treatment Coronavirus (COVID-19). Treasure Island (FL): StatPearls Publishing
  6. 2020 January-Last Update: March 20, 2020. 9. Zhou P, Yang X, Wang X, Hu B, Zhang L. A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature 2020
  7. doi: 10.1038/s41586-020- 2012-7 10. Chan JF, Kok KH, Zhu Z, Chu H, To KK et al. Genomic characterization of the 2019 novel human-pathogenic coronavirus isolated from a patient with atypical pneumonia after visiting Wuhan. Emerging Microbes and Infections 2020
  8. 9 (1): 221-236. doi: 10.1080/22221751.2020.1719902 11. W. Li, M.J. Moore, N. Vasilieva, Sui J, Wong BK et al. Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus. Nature 2003
  9. doi: 10.1038/nature02145 12. Li X, Geng M, Peng Y, Meng L, Lu S. Molecular immune pathogenesis and diagnosis of COVID-19. Journal of Pharmaceutical Analysis 2